作者更正：3q26.31-32位点的基因改变赋予侵袭性前列腺癌表型。
Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
作者信息
Simpson Benjamin S, Camacho Niedzica, Luxton Hayley J, Pye Hayley, Finn Ron, Heavey Susan, Pitt Jason, Moore Caroline M, Whitaker Hayley C
机构信息
Molecular Diagnostics and Therapeutics Group, Research Department of Targeted Intervention, Division of Surgery & Interventional Science, University College London, London, UK.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
出版信息
Commun Biol. 2020 Oct 8;3(1):570. doi: 10.1038/s42003-020-01291-8.
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
摘要
本文的一个修订版本已发表，可通过本文顶部的链接获取。
相似文献
1
Author Correction: Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.作者更正：3q26.31-32位点的基因改变赋予侵袭性前列腺癌表型。
Commun Biol. 2020 Oct 8;3(1):570. doi: 10.1038/s42003-020-01291-8.
2
Author Correction: The evolutionary history of lethal metastatic prostate cancer.作者更正：致命转移性前列腺癌的进化史。
Nature. 2020 Aug;584(7820):E18. doi: 10.1038/s41586-020-2581-5.
3
Author Correction: Metabolism of multiple glycosaminoglycans by Bacteroides thetaiotaomicron is orchestrated by a versatile core genetic locus.作者更正：多形拟杆菌对多种糖胺聚糖的代谢由一个多功能核心基因座协调。
Nat Commun. 2020 Aug 28;11(1):4396. doi: 10.1038/s41467-020-18097-1.
4
Author Correction: Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequence.作者更正：使用改良的Look-Locker反转恢复序列评估前列腺癌和良性前列腺组织中的T1弛豫时间。
Sci Rep. 2020 Mar 18;10(1):5249. doi: 10.1038/s41598-020-61549-3.
5
Author Correction: Anticancer polymers designed for killing dormant prostate cancer cells.作者更正：设计用于杀死休眠前列腺癌细胞的抗癌聚合物。
Sci Rep. 2019 Nov 25;9(1):17455. doi: 10.1038/s41598-019-53859-y.
6
Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.作者更正：FOXA1突变改变先锋活性、分化及前列腺癌表型。
Nature. 2020 Sep;585(7826):E20. doi: 10.1038/s41586-020-2678-x.
7
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.作者更正：MUC1-C调节谱系可塑性驱动神经内分泌前列腺癌进展。
Nat Commun. 2020 Feb 24;11(1):1095. doi: 10.1038/s41467-020-14808-w.
8
Author Correction: Evaluation of Radiation dosimetry of Tc-HYNIC-PSMA and imaging in prostate cancer.作者更正：锝[99mTc]标记的HYNIC-PSMA在前列腺癌中的辐射剂量学评估及成像
Sci Rep. 2020 Oct 23;10(1):18494. doi: 10.1038/s41598-020-74851-x.
9
Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate.作者更正：异常的视网膜电图（ERG）表达与磷酸酶及张力蛋白同源物（PTEN）缺失协同作用，促进前列腺癌进展。
Nat Genet. 2020 Sep;52(9):984. doi: 10.1038/s41588-020-0688-0.
10
Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.作者更正：LRIG1是前列腺癌中一种多效性雄激素受体调节的反馈肿瘤抑制因子。
Nat Commun. 2020 Jun 4;11(1):2895. doi: 10.1038/s41467-020-16615-9.
Zotero 插件